BioCorRx (BICX) Change in Receivables (2011 - 2026)
BioCorRx's (BICX) quarterly Change in Receivables came in at $76889.0 in Q1 2026, down 49.86% year-on-year from $153360.0 in Q1 2025, and up 4.19% quarter-over-quarter from $73796.0 in Q4 2025.
BioCorRx (BICX) Change in Receivables (2011 - 2026) Analysis & Trends
BioCorRx has disclosed Change in Receivables across 16 years of filings, most recently posting $76889.0 for Q1 2026.
- Change in Receivables for Q1 2026 came in at $76889.0, down 49.86% year-over-year; the trailing twelve-month figure through Mar 2026 was -$24445.0 (down 132.02% YoY), and the FY2025 annual result was $52026.0, up 168.22% from the prior year.
- Change in Receivables came in at $76889.0 for Q1 2026 at BioCorRx, up from $73796.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $161638.0 in Q4 2024 to a low of -$237164.0 in Q3 2024.
- The 5-year median for Change in Receivables is $2572.0 (2022), against an average of $3052.3.
- Across the five-year window, Change in Receivables sank 1884.14% in 2023 and soared 20624.32% in 2025, its largest moves.
- BioCorRx's Change in Receivables stood at $99070.0 in 2022, then sank by 158.34% to -$57801.0 in 2023, then soared by 379.65% to $161638.0 in 2024, then sank by 54.34% to $73796.0 in 2025, then increased by 4.19% to $76889.0 in 2026.
- The last three Change in Receivables figures came in at $76889.0 (Q1 2026), $73796.0 (Q4 2025), and -$175498.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | 463.00 Mn |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 28.00 Mn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 29.75 Mn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 53.20 Mn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 24.01 Mn |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 123.86 Mn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 218.12 Mn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 32.90 Mn |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 11.22 Mn |
| 10 | BioCorRx | - | - | 189,355.00 | 76,889.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76,889.00 |
| Mar 31, 2026 | 76,889.00 |
| Dec 31, 2025 | 73,796.00 |
| Dec 31, 2025 | 73,796.00 |
| Sep 30, 2025 | -175,498.00 |
| Sep 30, 2025 | -175,498.00 |
| Jun 30, 2025 | 368.00 |
| Jun 30, 2025 | 368.00 |
| Mar 31, 2025 | 153,360.00 |
| Mar 31, 2025 | 153,360.00 |
| Dec 31, 2024 | 161,638.00 |
| Dec 31, 2024 | 161,638.00 |
| Sep 30, 2024 | -237,164.00 |
| Sep 30, 2024 | -237,164.00 |
| Jun 30, 2024 | -1,480.00 |
| Jun 30, 2024 | -1,480.00 |
| Mar 31, 2024 | 740.00 |
| Mar 31, 2024 | 740.00 |
| Dec 31, 2023 | -57,801.00 |
| Dec 31, 2023 | -57,801.00 |